United States · 
Who invested in Belhaven Biopharma?
Belhaven Biopharma's investors include North Carolina Biotechnology Center.
United States · Series A startup
Who invested in Belhaven Biopharma
Funding summaryUpdated 26 Oct 2026
$10Mraised across 1 round since 2025, from 1 source
- Latest round
- Series A, $10MAug 2025
- Investors
- 1
The rounds
- Aug 2025Series A$10M
Source recordedSEC filing: $32M sold, first sale Aug 2025
Founders and team
From Belhaven Biopharma's own website: 6 on the team.
- Scott LymanChief Executive Officer and Chairman of the Board
- Brian TaubenheimChief Operations Officer
- Dave NealChief Financial Officer and Board Member
- Anthony HickeyPhD: Chairman
- Derek M. WinstanlyIndependent Board Member
- Wes WheelerIndependent Board Member
Everyone who backed them
Missing a round, or an investor who was in one? Tell us.
Also claim to have backed them
This firm lists Belhaven Biopharma as a portfolio company on their own website, but no report of a round names it. They are the firms' own claims, kept apart from the rounds above.
Quick answers about Belhaven Biopharma
How much has Belhaven Biopharma raised?
Belhaven Biopharma has raised $10M across 1 round since 2025.
When did Belhaven Biopharma last raise?
Belhaven Biopharma's most recent round was a Series A of $10M in Aug 2025.
What was Belhaven Biopharma's biggest round?
Its most recent round, $10M in Aug 2025, is also its largest on record.
Who backed Belhaven Biopharma first?
Belhaven Biopharma's first round on record, in Aug 2025, was backed by North Carolina Biotechnology Center.
What stage is Belhaven Biopharma at?
Belhaven Biopharma's latest named round is a Series A, in Aug 2025.
Where is Belhaven Biopharma based?
Belhaven Biopharma is based in the United States.
Companies like Belhaven Biopharma
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.